SURTAVI Trials: Five year incidence, timing and predictors of
hemodynamic valve deterioration of transcatheter and surgical aortic
bioprostheses (AYELEN LECLERQ)
ADAPT-TAVR: Edoxaban Versus Dual Antiplatelet Therapy For Valve
Thrombosis and Cerebral Thromboembolism After Transcatheter
Aortic-valve Replacement. (LUCIA MARTINO)
